Tastemaker Acquisition Corp
Change company Symbol lookup
Select an option...
TMKR Tastemaker Acquisition Corp
SPY SPDR® S&P 500 ETF Trust
STOR STORE Capital Corp
PIPP^ Pine Island Acquisition Corp
PEP PepsiCo Inc
$NASI5000LMN NASDAQ Asia Cnsmr Svcs Large Mid Cap
PNM PNM Resources Inc
CBLAQ CBL & Associates Properties Inc
APLE Apple Hospitality REIT Inc
MET MetLife Inc
Go

Company profile

Tastemaker Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses. The Company has not selected any specific business combination target and may pursue an initial business combination target in any industry or geographic region. The Company is not engaged in any business and has not generated any revenue.

Closing Price
$9.86
Day's Change
-0.01 (-0.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.90
Day's Low
9.78
Volume
128,131

(CHNG) Alert: Johnson Fistel Investigates Proposed Sale of Change Healthcare; Is $25.75 a Fair Price?

8:18 am ET January 6, 2021 (PR Newswire) Print

Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Change Healthcare (NASDAQ: CHNG) breached their fiduciary duties in connection with the proposed sale of the Company to UnitedHealth Group (NYSE: UNH) ("UnitedHealth").

On January 4, 2021, Change Healthcare announced that it had entered into a definitive merger agreement with UnitedHealth. Under the terms of the deal, Change Healthcare stockholders will receive $ 25.75 per share in cash.

The investigation concerns whether the Change Healthcare board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Change Healthcare shares of common stock.

If you are a shareholder of Change Healthcare and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:Johnson Fistel, LLPJim Baker, 619-814-4471jimb@johnsonfistel.com

[Click here to join this action]

https://c212.net/c/img/favicon.png?sn=PH38861&sd=2021-01-06

View original content:http://www.prnewswire.com/news-releases/chng-alert-johnson-fistel-investigates-proposed-sale-of-change-healthcare-is-25-75-a-fair-price-301201986.html

SOURCE Johnson Fistel, LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=PH38861&Transmission_Id=202101060818PR_NEWS_USPR_____PH38861&DateId=20210106

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.